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ORIGINAL ARTICLE 
HYPERLACTETEMIA AND ITS TRENDS IN CRITICALLY ILL 
CHILDREN ADMITTED IN PEDIATRIC INTENSIVE CARE UNIT OF A 
DEVELOPING COUNTRY 
Qalab Abbas, Muhammad Tariq Jamil, Vivek Khetpal, Leena Jafri*, Anwar ul Haque 
Department Of Paediatrics and Child Health, *Department of Pathology and Laboratory Medicine 
Aga Khan University Karachi-Pakistan 
Background: There is increasing evidence that in setting of critical ailments clinical signs 
lag biomarkers like Lactate and hyperlactetemia can be the only marker for this disorder. 
This study was conducted to describe the incidence of hyperlactatemia in critically ill 
children and its association with outcome. Methods: Retrospective review of medical 
records of all children who had their lactic acid (LA) levels measured during their 
admission in PICU from January 2014 to December 2015 was done. Demographic and 
clinical variables were recorded along with PICU therapies, outcome (Survived or expired) 
and development of multi-organ dysfunction. Results are presented as frequency with 
percentages and mean with standard deviation. Appropriate statistical tests were applied 
and p-value of <0.05 was taken as significant. Results: Total 300 patients had their LA 
measured and 202 were included in the study. Males were 130 (64%) and mean age was 
5.7±4.6 years. Hyperlactatemia was found in 68 (33%) patients and another 75 (37%) had a 
second LA level >4 mmol/L. Increasing LA trend was found in 79 (39%) patients. 
Diagnostic categories included cardiovascular diseases (45, 22%), central nervous system 
diseases (40, 20%), respiratory diseases (31, 15%), sepsis (28, 14%), and gastrointestinal 
diseases14 (7%). 168 (83%) needed mechanical ventilation. Mean pH was 7.31±0.15 and 
metabolic acidosis was observed in 91 patients (45%). Mean LA levels in survivors and non 
survivors were 3.3±3.12 and 5.35±5.47 respectively. Hyperlactatemia was associated with 
death (p=0.01) and development of MODS (p=0.03) on univariate analysis. On multivariate 
logistic regression rising lactate and development of MODS were significantly associated 
with death (p=<0.05, odds ratio (OR) 9.24 (95% confidence interval 1.55–55.20). 
Conclusion: Hyperlactatemia and increasing LA trend in critically ill children are 
associated with worse outcome in PICU. 
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INTRODUCTION 
Critically ill children due to various underlying 
disease processes often have diminished tissue 
perfusion. Delay in recognition of hypoperfusion 
leads to development of multi-organ dysfunction 
syndrome (MODS). This results in morbidity and 
increased mortality until it is timely recognized 
and promptly reversed.1 There is increasing 
evidence available that clinical signs lag 
biomarkers like Lactate and tissue hypoperfusion 
do not always show clinical signs, 
hyperlactetemia can be the only marker for this 
disorder.1,2 Lactic acid (LA), a by-product of 
anaerobic metabolism has been used as a 
biomarker and indicator of tissue hypoxia.2 This 
tissue hypoxia may result from respiratory or 
circulatory disorders. 
Hyperlactatemia has been found to be 
associated with worse outcome in critically ill 
patients.3 Its levels and clearance has also been 
shown to be associated with prognosis in few 
conditions.4 While hyperlactetemia has been 
investigated in some specific clinical scenarios 
like cardiogenic shock, trauma, sepsis, lactate 
may also be increased in various other conditions. 
Only few studies have been conducted in children 
to evaluate the role of measurement of LA in 
general population of critically ill children in 
paediatric intensive care unit (PICU).5,6 
We report the incidence of 
hyperlactetemia and its relationship with outcome 
in critically ill children admitted in PICU of a 
developing country. 
MATERIAL AND METHODS 
This study was carried out in PICU of Aga Khan 
University Hospital (AKUH) which is a 500 
bedded tertiary care hospital. PICU at AKUH is 
four-bedded closed multidisciplinary unit fully 
equipped with advanced technology with around 
450 annual admissions and is staffed by 
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fellowship trained full-time paediatric 
intensivists. 
Retrospective chart review of all children 
(aged 1 month to 16 years) admitted in PICU 
between January 2012 to December 2014 and had 
a plasma LA measured was done. Study was 
approved by ethical review committee (ERC) of 
the AKUH. Patient’s medical records were taken 
from PICU log and rechecked with laboratory 
data for LA measurement. Patients with a 
diagnosis of inherited metabolic disorder and 
patients who remained in PICU for <24 hours 
were excluded from the study. 
Plasma Lactate levels were obtained in 
potassium oxalate/sodium fluoride vacutainer 
tubes by a free flow blood samples from arterial 
or central/peripheral venous lines and were 
transported to laboratory in ice within 10 minutes. 
Plasma lactate was measured in laboratory by 
photometric lactate oxidase enzymatic method on 
ADVIA 1800 chemistry system, by Siemens. . 
For quality control three levels of internal quality 
control materials were used with each batch of 
analysis. Values of LA were expressed in 
mmol/L. During the study period College of 
American Pathologists proficiency testing surveys 
for lactate were also run and were acceptable. 
Patients who had more than one LA 
levels measured, the first two levels were 
included for analysis. A trend of these levels were 
noted and labelled as increasing or decreasing. 
Hyperlactatemia was defined as LA levels >4 
mmol/L based on the data by Bai et al who 
showed an acceptable sensitivity and specificity 
of LA for prediction of mortality at LA levels >4 
mmol/l.6 
Data was collected on a structured 
proforma and included demographic details (age, 
gender), and clinical variables like admitting 
diagnosis based on dominantly involved system, 
values of serum creatinine, blood gas analysis, 
serum electrolytes and serial LA. Data will also 
be collected on PICU therapies like use of 
mechanical ventilation, inotrops and development 
of MODS. MODS was defined as per IPSC 2003 
definition.7 Primary outcome was mortality and 
development of MODS. 
Based on LA levels patients were divided 
into two groups and labelled as High LA group 
(LA>4) and Normal LA group (LA <4). 
All the data was entered into SPSS v 20. 
Frequencies with percentages are reported for 
categorical variables and mean with standard 
deviation (SD) for continuous variables. 
Appropriate test (Chi square test and t-test) was 
applied and p-value of <0.05 was taken as 
significant. A logistic regression analysis was 
performed to determine the factor predicting 
PICU mortality. 
RESULTS 
A total 300 patients were identified who had 
their plasma lactate levels measured out of 933 
total admissions and 202 (21.6%) patients were 
included in the study based on the inclusion and 
exclusion criteria. Males were 130 (64%) and 
mean age of the study population was 5.7±4.6 
years. Hyperlactetemia was found in 68 (33%) 
patients who had their LA levels measure and 75 
(37%) patients had a second LA level >4 mmol/l. 
Increasing serum lactate trend was observed in 79 
(39%) patients.  
Diagnostic categories included cardiovascular 
diseases (45, 22%), central nervous system diseases 
including infections (40, 20%), respiratory diseases (31, 
15%), sepsis (28, 14%), 14 with gastrointestinal diseases 
and the rest had other problems (Table-1).  
Major individual diagnosis included acute 
respiratory failure (22), shock (20), status epilepticus 
(15), and cardiac failure secondary to myocarditis (12), 
congenital heart disease (10) or cardiomyopathy (5), and 
acute liver failure (8). Fifteen patients had secondary 
liver dysfunction as part of MODS. Two patients were 
admitted with Acute Kidney injury (AKI) and another 
40 patients demonstrated AKI as part of MODS. One 
hundred eighty-eight patients (93%) were admitted from 
emergency room (ER), nine patients were admitted from 
operating room (OR) and five patients from ward.  
In PICU 168 (83%) patients needed 
mechanical ventilation, and. MODS was found in 74 
(36%) patients while 31 patients (15%) needed 
cardiopulmonary resuscitation (CPR). twenty-three 
(11%) patients needed renal replacement therapy 
(peritoneal dialysis in 10 patients and continuous renal 
replacement therapy in 13 patients). 
Metabolic acidosis was present in 91 patients 
(45%). Mean pH was 7.31 with a standard deviation 
(SD) ±0.15 and mean first and second LA levels were 
4.08 mmol/l±4.2 and 4.35±4.65 respectively. Mean LA 
levels in non survivors and survivors were 5.35±5.47 
mmol/L and 3.3±3.12 mmol/L respectively. 
On univariate analysis hyperlactetemia and 
increasing LA trend were significantly associated with 
death (p=0.01) and development of MODS (p=0.032). 
On multivariate logistic regression analysis increasing 
LA trend and development of MODS were significantly 
associated with death. (Table-1). 
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Table-1: Characteristics of overall study population and difference between survivors and non survivors (n= 202) 
Variable 
Overall 
n (percent) 
Survivor 
n (percent) 
Non Survivor 
n (percent) 
p-value 
Odd Ratio (95% 
Confidence Interval) 
Adjusted Odds 
Ratio 
Gender (Male) 130 (64) 77 (38) 53 (26) 0.29 1.37 (0.75–2.51)  
Age (Mean±SD*) 5.78±4.60 5.4±4.47 6.3±4.78 0.20   
CNS+ 40 (20) 28 (14) 12 (6) 
CVS- 45 (22) 28 (14) 17 (8) 
Infections 28 (14) 17 (8) 11 (6) 
Respiratory 31 (15) 19 (9) 12 (6) 
Post-Surgical 15 (7) 10 (5) 5 (2) 
Trauma 12 (6) 7 (3.5) 5 (2.5) 
Admitting 
Diagnostic 
Category 
GI” 14 (7) 6 (3) 8 (4) 
0.59   
ER# 188 (93) 115 (57) 73 (36) 
OR  ^ 9 (4.5) 7 (3.5) 2 (1) 
Admission 
Source 
Ward 5 (2.5) 3 (1.5) 2 (1) 
0.60   
Mechanical Ventilation 168 (83) 94 (46.5) 74 (36.5) 0.00 0.12 (0.036–0.41) 0.95 (0.244–3.75) 
Serum Creatinine (Mean±SD) 0.9±1.03 0.86±1.16 0.99±0.78 0.35   
MODS@ 74 (36) 4 (2) 70 (34) 0.00 0.003 (0.001–0.012) 0.002 (0.00–0.13) 
Renal Replacement Therapy 23 (11) 9 (4) 14 (7) 0.17 2.86 (1.17–6.98) 6.40 (1.01–40.38) 
=ALT (Mean ± SD) 354±984 233±759 539±1236 0.62   
First LA$ Levels (Mean±SD) 4.08±4.26 3.3±3.1 5.3±5.4 0.005   
Second LA levels 4.35±4.65 3.1±3.4 6.3±5.6 0.00   
Hyperlactatemia in First Level 69 (17) 34 (17) 35 (17) 0.008 0.45 (0.25–0.81) 0.29 (0.058–1.46) 
Hyperlactatemia in Second Level 75 (37) 32 (16) 43 (21) 0.00 0.27 (0.14–0.49) 1.73 (0.29–10.22) 
Increasing LA Trend 79 (39) 34 (17) 45 (22) 0.00 3.74 (2.06–6.86) 9.24 (1.55–55.20) 
CPR~ 31 (15) 4 (2) 27 (13) 0.00 0.061 (0.020–0.18) 1.29 (0.17–9.71) 
*Standard Deviation, +Central Nervous System, - Cardiovascular System, “Gastrointestinal System, #Emergency Room, ^Operating Room,@ 
Multiorgan Dysfucntion Syndrome, = Alanine Transaminase, $Lactic Acid, ~Cardiopulmonary Resuscitation 
 
DISCUSSION 
This study provides data on plasma lactate levels in a 
hetergenous group of critically ill children admitted 
in PICU of a developing country. Our results show that 
7% of patient admitted in PICU had hyperlactatemia 
and 39% of them had an increasing LA trend. This is 
similar to that shown by Hatherill et al but low as 
compared to previous data from adults which showed it 
to be 20–30% in general medical ICU and cardiac 
surgery.8–10 These differences could be due to variation 
in disease states and or time of presentation or time of 
checking LA levels. Majority of the patients had 
cardiovascular system disease like myocarditis, 
cardiomyopathy and different congenital heart diseases 
followed by central nervous system disease like status 
epileptics and respiratory diseases like pneumonia. 
Other diagnosis included infections including septic 
shock. This shows that patients other than septic shock 
or heart surgery can also have raised LA level due to 
similar underlying mechanism of tissue hypoxia.11,12 
Thirty-three patients with first high LA levels developed 
MODS and 41 patients with MODS had a second high 
LA. Overall 91 patients had metabolic acidosis on 
ABGs while LA was elevated only in 68 patients. One 
Hundred twenty-five patients (62%) from the study 
population expired. Almost all patients who 
demonstrated an increasing LA levels expired (77/79). 
Increased LA trend could be due to continuous LA 
production because of progressive disease process, 
tissue hypoxia and organ damage or it could also be due 
to decreased LA clearance due to renal or liver 
failure.13 LA has also been shown to be produced by 
mechanism other than anaerobic metabolism.13 
Failure to clear LA is considered superior than an 
isolated single LA value as has been shown by recent 
studies.5,14 High LA levels and increasing LA trends 
were significantly associated with very high mortality 
in our study. Serial LA monitoring could be more 
meaningful than a single value as it can provide 
information on the response to resuscitation and 
ongoing tissue oxygen deficit and damage to 
organs.10,15 This will in turn help in early recognition 
and prompt reversal as well as titrate the resuscitation 
efforts and also predict outcome.  
Strengths and limitation: To the best of our 
knowledge this is the first comprehensive report from 
PICU of Pakistan and the population studied 
represents a heterogeneous group with various 
underlying conditions. Our study has the limitations 
of being a retrospective study with uncontrolled 
limited data from a single centre. PRISM III score 
was not calculated. 
CONCLUSION 
Hyperlactatemia and increasing LA trend in critically ill 
children are associated with worse outcome in PICU. 
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